# A novel insA2933 causes premature termination of translation and is accompanied by overexpression of truncated androgen receptor gene in a patient with complete androgen insensitivity syndrome

**Authors:** J. Turek-Plewa, J. B. Starzyk, W. H. Trzeciak

PMC · DOI: 10.1007/s13353-015-0288-3 · Journal of Applied Genetics · 2015-05-22

## TL;DR

A new mutation in the androgen receptor gene causes a truncated protein in a patient with complete androgen insensitivity syndrome, leading to a female phenotype despite having XY chromosomes.

## Contribution

The study identifies a novel A2933 insertion in the AR gene that causes a truncated receptor and altered gene expression in CAIS.

## Key findings

- The A2933 insertion changes a Tyr codon to a termination codon, resulting in a non-functional androgen receptor.
- The patient's AR transcript levels were higher than in family members, possibly due to disrupted interaction with IFI-16.
- The mutation leads to conformational changes in the receptor's hormone-binding pocket, impairing ligand binding.

## Abstract

A patient with a female phenotype, 46,XY karyotype, and a diagnosis of complete androgen insensitivity syndrome (CAIS) was examined. Her mother and three 46,XX sisters were also included in the study. Sequence analysis of the androgen receptor gene (AR) revealed a novel A2933 insertion that alters the Tyr codon to a termination codon (Y857X), resulting in a truncated form of the receptor. Computer simulation revealed major conformational changes in the hydrophobic pocket that accommodates the hormone. An insA2933 results in a truncated receptor incapable of binding the ligand and is responsible for the clinical symptoms of CAIS in the patient. The levels of the AR transcript in peripheral blood leukocytes were higher in the patient than in her heterozygous mother and her heterozygous sister, as well as in the two healthy sisters. It is hypothesized that elevated levels of the AR transcript in the patient might be caused by the inability of the truncated receptor to react with IFI-16, which functions in complex with AR to inhibit the expression of the AR gene.

## Linked entities

- **Genes:** AR (androgen receptor) [NCBI Gene 367]
- **Proteins:** IFI16 (interferon gamma inducible protein 16)
- **Diseases:** complete androgen insensitivity syndrome (MONDO:0021023), CAIS (MONDO:0021023)

## Full-text entities

- **Genes:** GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IFI16 (interferon gamma inducible protein 16) [NCBI Gene 3428] {aka IFNGIP1, PYHIN2}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, ARID2 (AT-rich interaction domain 2) [NCBI Gene 196528] {aka BAF200, CSS6, SMARCF3, ZIPZAP, p200}
- **Diseases:** inguinal hernia (MESH:D006552), sexual development disturbances (MESH:D012734), complete (MESH:D001766), AIS (MESH:D013734), LBD (MESH:D006938)
- **Chemicals:** DHT (MESH:D013196), Poly A+ (MESH:D011061), TRItidy (-), Testosterone (MESH:D013739), estradiol (MESH:D004958), T (MESH:D014316)
- **Species:** Moloney murine leukemia virus (no rank) [taxon 11801], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Pro817Leu, A2933, C2933G, Y857X, Tyr codon to a termination codon, Tyr codon to a termination codon, Tyr857, Y857X
- **Cell lines:** LNCaP prostate cancer — Homo sapiens (Human), Metastatic prostate neuroendocrine carcinoma, Cancer cell line (CVCL_C0UV)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4617858/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4617858/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC4617858/full.md

---
Source: https://tomesphere.com/paper/PMC4617858